This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

24-26 Feb, 2026

Grand Nikko Tokyo DaibaTokyo

Matthew Quinn
Novo Nordisk における Manager, Analytical Development, Global Nucleic Acid Therapies
スピーカー

アジェンダセッション

An Overlapping Fragment Approach to Diastereomer Analysis: Sensitivity and Linearity
26 2月, 9:15am
セッションを見る

このイベントで

前へ

次へ

El Djouhar Rekaï, PhD

Head of Peptide Process Development & Manufacturing

PolyPeptide Group